Global 3D Bioprinted Human Tissue Market 2026 by Company, Regions, Type and Application, Forecast to 2032

April 2026 | 103 pages | ID: G8761714D350EN
GlobalInfoResearch

Abstracts

According to our (Global Info Research) latest study, the global 3D Bioprinted Human Tissue market size was valued at US$ 740 million in 2025 and is forecast to a readjusted size of US$ 2173 million by 2032 with a CAGR of 18.5% during review period.

3D Bioprinted Human Tissue generally refers to human tissue models or implantable tissue products with specific spatial structures and some physiological functions, constructed through a layer-by-layer deposition process using computer-aided design, cells, bio-inks, and biomaterials. Academic reviews generally define it as: using bioprinting technology to precisely arrange living cells, scaffold materials, and bioactive factors to simulate the microstructure, intercellular interactions, and some organ functions of natural tissues, for applications such as disease modeling, drug screening, regenerative medicine, and tissue replacement. The average gross profit margin of this product is 55%.

The demand for more predictive human models in drug development is currently the most realistic market driver. The FDA has included advanced human models such as engineered 3D tissues and microphysiological systems in its regulatory science activities within the framework of 'advancing drug review and alternative models,' indicating that regulators are increasingly recognizing the value of these new methods in efficacy and safety assessments. Organovo has long used 3D bioprinted human tissues for toxicology and disease modeling, emphasizing that its tissue models can support more translational drug research. The long-term potential of regenerative medicine and tissue therapy is attracting capital and industry collaborations. Aspect Biosystems has recently been explicitly advancing implantable bioprinted tissue therapeutics and has secured substantial funding for pharmaceutical collaborations, demonstrating that the capital market views this technology as a potential extension of cell therapy and tissue engineering.

The 3D Bioprinted Human Tissue market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation

3D Bioprinted Human Tissue market is split by Type and by Application. For the period 2026-2032, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type,

• Skeleton
• Blood Vessel
• Cartilage
• Bladder
• Skin
• Muscle
• Other

Market segment by Product Research

• In Vitro Human Tissue Models
• Implantable Tissue Therapy Products

Market segment by Application

• Medical Education
• Clinical Practice
• Research and Development
• Others

Market segment by players, this report covers

• CELLINK
• Merck KGaA
• Organovo
• Stratasys
• 3D Systems
• ReproCELL
• Materialise NV
• Cyfuse Biomedical
• CN Bio
• Prellis Biologics
• Aspect Biosystems

Market segment by regions, regional analysis covers

North America

Europe
Asia-Pacific (China, Japan, South Korea, Rest of Asia)

South America

Middle East & Africa

Contents

1 MARKET OVERVIEW

1.1 Product Overview and Scope of 3D Bioprinted Human Tissue
1.2 Classification of 3D Bioprinted Human Tissue by Type
  1.2.1 Overview: Global 3D Bioprinted Human Tissue Market Size by Type: 2026 Versus 2032
  1.2.2 Global 3D Bioprinted Human Tissue Revenue Market Share by Type in 2032
  1.2.3 Skeleton
  1.2.4 Blood Vessel
  1.2.5 Cartilage
  1.2.6 Bladder
  1.2.7 Skin
  1.2.8 Muscle
  1.2.9 Other
1.3 Classification of 3D Bioprinted Human Tissue by Product Research
  1.3.1 Overview: Global 3D Bioprinted Human Tissue Market Size by Product Research: 2026 Versus 2032
  1.3.2 Global 3D Bioprinted Human Tissue Revenue Market Share by Product Research in 2032
  1.3.3 In Vitro Human Tissue Models
  1.3.4 Implantable Tissue Therapy Products
1.4 Global 3D Bioprinted Human Tissue Market by Application
  1.4.1 Overview: Global 3D Bioprinted Human Tissue Market Size by Application: 2026 Versus 2032
  1.4.2 Medical Education
  1.4.3 Clinical Practice
  1.4.4 Research and Development
  1.4.5 Others
1.5 Global 3D Bioprinted Human Tissue Market Size & Forecast
1.6 Market Drivers, Restraints and Trends
  1.6.1 3D Bioprinted Human Tissue Market Drivers
  1.6.2 3D Bioprinted Human Tissue Market Restraints
  1.6.3 3D Bioprinted Human Tissue Trends Analysis

2 COMPANY PROFILES

2.1 CELLINK
  2.1.1 CELLINK Details
  2.1.2 CELLINK Major Business
  2.1.3 CELLINK 3D Bioprinted Human Tissue Product and Solutions
  2.1.4 CELLINK Recent Developments and Future Plans
2.2 Merck KGaA
  2.2.1 Merck KGaA Details
  2.2.2 Merck KGaA Major Business
  2.2.3 Merck KGaA 3D Bioprinted Human Tissue Product and Solutions
  2.2.4 Merck KGaA Recent Developments and Future Plans
2.3 Organovo
  2.3.1 Organovo Details
  2.3.2 Organovo Major Business
  2.3.3 Organovo 3D Bioprinted Human Tissue Product and Solutions
  2.3.4 Organovo Recent Developments and Future Plans
2.4 Stratasys
  2.4.1 Stratasys Details
  2.4.2 Stratasys Major Business
  2.4.3 Stratasys 3D Bioprinted Human Tissue Product and Solutions
  2.4.4 Stratasys Recent Developments and Future Plans
2.5 3D Systems
  2.5.1 3D Systems Details
  2.5.2 3D Systems Major Business
  2.5.3 3D Systems 3D Bioprinted Human Tissue Product and Solutions
  2.5.4 3D Systems Recent Developments and Future Plans
2.6 ReproCELL
  2.6.1 ReproCELL Details
  2.6.2 ReproCELL Major Business
  2.6.3 ReproCELL 3D Bioprinted Human Tissue Product and Solutions
  2.6.4 ReproCELL Recent Developments and Future Plans
2.7 Materialise NV
  2.7.1 Materialise NV Details
  2.7.2 Materialise NV Major Business
  2.7.3 Materialise NV 3D Bioprinted Human Tissue Product and Solutions
  2.7.4 Materialise NV Recent Developments and Future Plans
2.8 Cyfuse Biomedical
  2.8.1 Cyfuse Biomedical Details
  2.8.2 Cyfuse Biomedical Major Business
  2.8.3 Cyfuse Biomedical 3D Bioprinted Human Tissue Product and Solutions
  2.8.4 Cyfuse Biomedical Recent Developments and Future Plans
2.9 CN Bio
  2.9.1 CN Bio Details
  2.9.2 CN Bio Major Business
  2.9.3 CN Bio 3D Bioprinted Human Tissue Product and Solutions
  2.9.4 CN Bio Recent Developments and Future Plans
2.10 Prellis Biologics
  2.10.1 Prellis Biologics Details
  2.10.2 Prellis Biologics Major Business
  2.10.3 Prellis Biologics 3D Bioprinted Human Tissue Product and Solutions
  2.10.4 Prellis Biologics Recent Developments and Future Plans
2.11 Aspect Biosystems
  2.11.1 Aspect Biosystems Details
  2.11.2 Aspect Biosystems Major Business
  2.11.3 Aspect Biosystems 3D Bioprinted Human Tissue Product and Solutions
  2.11.4 Aspect Biosystems Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global 3D Bioprinted Human Tissue Revenue and Share by Players (2026 & 2032)
3.2 3D Bioprinted Human Tissue Players Head Office, Products and Services Provided
3.3 3D Bioprinted Human Tissue Mergers & Acquisitions
3.4 3D Bioprinted Human Tissue New Entrants and Expansion Plans

4 GLOBAL 3D BIOPRINTED HUMAN TISSUE FORECAST BY REGION

4.1 Global 3D Bioprinted Human Tissue Market Size by Region: 2026 VS 2032
4.2 Global 3D Bioprinted Human Tissue Market Size by Region, (2026-2032)
4.3 North America
  4.3.1 Key Companies of 3D Bioprinted Human Tissue in North America
  4.3.2 Current Situation and Forecast of 3D Bioprinted Human Tissue in North America
  4.3.3 North America 3D Bioprinted Human Tissue Market Size and Prospect (2026-2032)
4.4 Europe
  4.4.1 Key Companies of 3D Bioprinted Human Tissue in Europe
  4.4.2 Current Situation and Forecast of 3D Bioprinted Human Tissue in Europe
  4.4.3 Europe 3D Bioprinted Human Tissue Market Size and Prospect (2026-2032)
4.5 Asia-Pacific
  4.5.1 Key Companies of 3D Bioprinted Human Tissue in Asia-Pacific
  4.5.2 Current Situation and Forecast of 3D Bioprinted Human Tissue in Asia-Pacific
  4.5.3 Asia-Pacific 3D Bioprinted Human Tissue Market Size and Prospect (2026-2032)
  4.5.4 China
  4.5.5 Japan
  4.5.6 South Korea
4.6 South America
  4.6.1 Key Companies of 3D Bioprinted Human Tissue in South America
  4.6.2 Current Situation and Forecast of 3D Bioprinted Human Tissue in South America
  4.6.3 South America 3D Bioprinted Human Tissue Market Size and Prospect (2026-2032)
4.7 Middle East & Africa
  4.7.1 Key Companies of 3D Bioprinted Human Tissue in Middle East & Africa
  4.7.2 Current Situation and Forecast of 3D Bioprinted Human Tissue in Middle East & Africa
  4.7.3 Middle East & Africa 3D Bioprinted Human Tissue Market Size and Prospect (2026-2032)

5 MARKET SIZE SEGMENT BY TYPE

5.1 Global 3D Bioprinted Human Tissue Market Forecast by Type (2026-2032)
5.2 Global 3D Bioprinted Human Tissue Market Share Forecast by Type (2026-2032)

6 MARKET SIZE SEGMENT BY APPLICATION

6.1 Global 3D Bioprinted Human Tissue Market Forecast by Application (2026-2032)
6.2 Global 3D Bioprinted Human Tissue Market Share Forecast by Application (2026-2032)

7 RESEARCH FINDINGS AND CONCLUSION

8 APPENDIX

8.1 Methodology
8.2 Research Process and Data Source
8.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Global 3D Bioprinted Human Tissue Revenue by Type, (USD Million) 2026 VS 2032
Table 2. Global 3D Bioprinted Human Tissue Revenue by Product Research, (USD Million) 2026 VS 2032
Table 3. Global 3D Bioprinted Human Tissue Revenue by Application, (USD Million), 2026 VS 2032
Table 4. CELLINK Corporate Information, Head Office, and Major Competitors
Table 5. CELLINK Major Business
Table 6. CELLINK 3D Bioprinted Human Tissue Product and Solutions
Table 7. Merck KGaA Corporate Information, Head Office, and Major Competitors
Table 8. Merck KGaA Major Business
Table 9. Merck KGaA 3D Bioprinted Human Tissue Product and Solutions
Table 10. Organovo Corporate Information, Head Office, and Major Competitors
Table 11. Organovo Major Business
Table 12. Organovo 3D Bioprinted Human Tissue Product and Solutions
Table 13. Stratasys Corporate Information, Head Office, and Major Competitors
Table 14. Stratasys Major Business
Table 15. Stratasys 3D Bioprinted Human Tissue Product and Solutions
Table 16. 3D Systems Corporate Information, Head Office, and Major Competitors
Table 17. 3D Systems Major Business
Table 18. 3D Systems 3D Bioprinted Human Tissue Product and Solutions
Table 19. ReproCELL Corporate Information, Head Office, and Major Competitors
Table 20. ReproCELL Major Business
Table 21. ReproCELL 3D Bioprinted Human Tissue Product and Solutions
Table 22. Materialise NV Corporate Information, Head Office, and Major Competitors
Table 23. Materialise NV Major Business
Table 24. Materialise NV 3D Bioprinted Human Tissue Product and Solutions
Table 25. Cyfuse Biomedical Corporate Information, Head Office, and Major Competitors
Table 26. Cyfuse Biomedical Major Business
Table 27. Cyfuse Biomedical 3D Bioprinted Human Tissue Product and Solutions
Table 28. CN Bio Corporate Information, Head Office, and Major Competitors
Table 29. CN Bio Major Business
Table 30. CN Bio 3D Bioprinted Human Tissue Product and Solutions
Table 31. Prellis Biologics Corporate Information, Head Office, and Major Competitors
Table 32. Prellis Biologics Major Business
Table 33. Prellis Biologics 3D Bioprinted Human Tissue Product and Solutions
Table 34. Aspect Biosystems Corporate Information, Head Office, and Major Competitors
Table 35. Aspect Biosystems Major Business
Table 36. Aspect Biosystems 3D Bioprinted Human Tissue Product and Solutions
Table 37. Global 3D Bioprinted Human Tissue Revenue (USD Million) by Players (2026 & 2032)
Table 38. Global 3D Bioprinted Human Tissue Revenue Share by Players (2026 & 2032)
Table 39. 3D Bioprinted Human Tissue Players Head Office, Products and Services Provided
Table 40. 3D Bioprinted Human Tissue Mergers & Acquisitions in the Past Five Years
Table 41. 3D Bioprinted Human Tissue New Entrants and Expansion Plans
Table 42. Global Market 3D Bioprinted Human Tissue Revenue (USD Million) Comparison by Region (2026 VS 2032)
Table 43. Global 3D Bioprinted Human Tissue Revenue Market Share by Region (2026-2032)
Table 44. Key Companies of 3D Bioprinted Human Tissue in North America
Table 45. Current Situation and Forecast of 3D Bioprinted Human Tissue in North America
Table 46. Key Companies of 3D Bioprinted Human Tissue in Europe
Table 47. Current Situation and Forecast of 3D Bioprinted Human Tissue in Europe
Table 48. Key Companies of 3D Bioprinted Human Tissue in Asia-Pacific
Table 49. Current Situation and Forecast of 3D Bioprinted Human Tissue in Asia-Pacific
Table 50. Key Companies of 3D Bioprinted Human Tissue in China
Table 51. Key Companies of 3D Bioprinted Human Tissue in Japan
Table 52. Key Companies of 3D Bioprinted Human Tissue in South Korea
Table 53. Key Companies of 3D Bioprinted Human Tissue in South America
Table 54. Current Situation and Forecast of 3D Bioprinted Human Tissue in South America
Table 55. Key Companies of 3D Bioprinted Human Tissue in Middle East & Africa
Table 56. Current Situation and Forecast of 3D Bioprinted Human Tissue in Middle East & Africa
Table 57. Global 3D Bioprinted Human Tissue Revenue Forecast by Type (2026-2032)
Table 58. Global 3D Bioprinted Human Tissue Revenue Forecast by Application (2026-2032)

List Of Figures

LIST OF FIGURES

Figure 1. 3D Bioprinted Human Tissue Picture
Figure 2. Global 3D Bioprinted Human Tissue Revenue Market Share by Type in 2032
Figure 3. Skeleton
Figure 4. Blood Vessel
Figure 5. Cartilage
Figure 6. Bladder
Figure 7. Skin
Figure 8. Muscle
Figure 9. Other
Figure 10. Global 3D Bioprinted Human Tissue Revenue Market Share by Product Research in 2032
Figure 11. In Vitro Human Tissue Models
Figure 12. Implantable Tissue Therapy Products
Figure 13. 3D Bioprinted Human Tissue Revenue Market Share by Application in 2032
Figure 14. Medical Education Picture
Figure 15. Clinical Practice Picture
Figure 16. Research and Development Picture
Figure 17. Others Picture
Figure 18. Global 3D Bioprinted Human Tissue Market Size, (USD Million): 2026 VS 2032
Figure 19. Global 3D Bioprinted Human Tissue Revenue and Forecast (2026-2032) & (USD Million)
Figure 20. 3D Bioprinted Human Tissue Market Drivers
Figure 21. 3D Bioprinted Human Tissue Market Restraints
Figure 22. 3D Bioprinted Human Tissue Market Trends
Figure 23. CELLINK Recent Developments and Future Plans
Figure 24. Merck KGaA Recent Developments and Future Plans
Figure 25. Organovo Recent Developments and Future Plans
Figure 26. Stratasys Recent Developments and Future Plans
Figure 27. 3D Systems Recent Developments and Future Plans
Figure 28. ReproCELL Recent Developments and Future Plans
Figure 29. Materialise NV Recent Developments and Future Plans
Figure 30. Cyfuse Biomedical Recent Developments and Future Plans
Figure 31. CN Bio Recent Developments and Future Plans
Figure 32. Prellis Biologics Recent Developments and Future Plans
Figure 33. Aspect Biosystems Recent Developments and Future Plans
Figure 34. Global 3D Bioprinted Human Tissue Revenue Market Share by Region (2026-2032)
Figure 35. Global 3D Bioprinted Human Tissue Revenue Market Share by Region in 2032
Figure 36. North America 3D Bioprinted Human Tissue Revenue (USD Million) and Growth Rate (2026-2032)
Figure 37. Europe 3D Bioprinted Human Tissue Revenue (USD Million) and Growth Rate (2026-2032)
Figure 38. Asia-Pacific 3D Bioprinted Human Tissue Revenue (USD Million) and Growth Rate (2026-2032)
Figure 39. South America 3D Bioprinted Human Tissue Revenue (USD Million) and Growth Rate (2026-2032)
Figure 40. Middle East & Africa 3D Bioprinted Human Tissue Revenue (USD Million) and Growth Rate (2026-2032)
Figure 41. Global 3D Bioprinted Human Tissue Market Share Forecast by Type (2026-2032)
Figure 42. Global 3D Bioprinted Human Tissue Market Share Forecast by Application (2026-2032)
Figure 43. Methodology
Figure 44. Research Process and Data Source